These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model. Heidebrecht HJ; Weiss WJ; Pulse M; Lange A; Gisch K; Kliem H; Mann S; Pfaffl MW; Kulozik U; von Eichel-Streiber C Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30736358 [TBL] [Abstract][Full Text] [Related]
23. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230 [TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile typhlitis associated with cecal mucosal hyperplasia in Syrian hamsters. Ryden EB; Lipman NS; Taylor NS; Rose R; Fox JG Lab Anim Sci; 1991 Dec; 41(6):553-8. PubMed ID: 1667196 [TBL] [Abstract][Full Text] [Related]
25. Colonization for the prevention of Clostridium difficile disease in hamsters. Sambol SP; Merrigan MM; Tang JK; Johnson S; Gerding DN J Infect Dis; 2002 Dec; 186(12):1781-9. PubMed ID: 12447764 [TBL] [Abstract][Full Text] [Related]
26. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion. Amadou Amani S; Shadid T; Ballard JD; Lang ML Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095 [TBL] [Abstract][Full Text] [Related]
27. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein. Ní Eidhin DB; O'Brien JB; McCabe MS; Athié-Morales V; Kelleher DP FEMS Immunol Med Microbiol; 2008 Mar; 52(2):207-18. PubMed ID: 18093141 [TBL] [Abstract][Full Text] [Related]
28. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies. Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar RH; Mikelsaar M; Verrips T; Hammarström L; Marcotte H Infect Immun; 2016 Feb; 84(2):395-406. PubMed ID: 26573738 [TBL] [Abstract][Full Text] [Related]
29. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Kink JA; Williams JA Infect Immun; 1998 May; 66(5):2018-25. PubMed ID: 9573084 [TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616 [TBL] [Abstract][Full Text] [Related]
31. Active and passive immunization against Clostridium difficile diarrhea and colitis. Giannasca PJ; Warny M Vaccine; 2004 Feb; 22(7):848-56. PubMed ID: 15040937 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Swanson RN; Hardy DJ; Shipkowitz NL; Hanson CW; Ramer NC; Fernandes PB; Clement JJ Antimicrob Agents Chemother; 1991 Jun; 35(6):1108-11. PubMed ID: 1929250 [TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Aboudola S; Kotloff KL; Kyne L; Warny M; Kelly EC; Sougioultzis S; Giannasca PJ; Monath TP; Kelly CP Infect Immun; 2003 Mar; 71(3):1608-10. PubMed ID: 12595488 [TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744 [TBL] [Abstract][Full Text] [Related]
35. Immune responses to Clostridium difficile infection. Madan R; Petri WA Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763 [TBL] [Abstract][Full Text] [Related]
36. A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile. Zhang BZ; Cai J; Yu B; Hua Y; Lau CC; Kao RY; Sze KH; Yuen KY; Huang JD BMC Infect Dis; 2016 Oct; 16(1):596. PubMed ID: 27770789 [TBL] [Abstract][Full Text] [Related]
37. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Salcedo J; Keates S; Pothoulakis C; Warny M; Castagliuolo I; LaMont JT; Kelly CP Gut; 1997 Sep; 41(3):366-70. PubMed ID: 9378393 [TBL] [Abstract][Full Text] [Related]
38. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model. Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821 [TBL] [Abstract][Full Text] [Related]
39. Effects of Clostridium difficile toxins given intragastrically to animals. Lyerly DM; Saum KE; MacDonald DK; Wilkins TD Infect Immun; 1985 Feb; 47(2):349-52. PubMed ID: 3917975 [TBL] [Abstract][Full Text] [Related]